Anavex's A2-73 Blarcamesine's trial results on 2 previously completed adult phase-3 trials were highly successful.

Complete Results!! !

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer's is the most valuable and most difficult indication and most desired lately.. and only Anavex really has some great results with a great safety record. .

The sava results trounce you guys 🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

Sava has good results. .

$BXRX The results from interim analysis are so good and think about the future huge market, its exciting

Phase 3 results were solid.

Results have been good.

We have achieved tremendous growth since launch SpiderNet ecosystem solutions business in December 2017 as a result continued expansion and monetization of AMTD SpiderNet ecosystem.

We have achieved tremendous growth since the launch of our SpiderNet ecosystem solutions business in December 2017 as a result of the continued expansion and monetization of AMTD SpiderNet ecosystem.

$HKD Earnings results or not, something explosive is about to happen here!

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$HKD positive financial results for YGMZ price at the bottom great opportunity

$HKD sky-rocketing a full quarter!! !

$HKD not even worried for some reason … I got til December …will double my position this month if she goes under $30…market is shit this quarter this seems like a better bet 😂😂😂🤷🏾‍♀️

It’s been a while since $hkd has had a good regular hours run, lately I’ve been noticing with these stocks that run 60%, the following day they tend to repeat themselves with even better results.